Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

CLL Society’s Official Statement Concerning Prioritizing CLL (Chronic Lymphocytic Leukemia) Patients When Triaging Care During the COVID-19 Pandemic

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

Take it with you! CLL Society’s Official COVID-19 Triage Statement

CLL Society has authored an Official Statement to help you help your healthcare providers understand CLL patients’ unique vulnerabilities to COVID-19 and our higher risks of serious complications.

This letter to your healthcare provider may help you be attended to faster, should you have any COVID-19 symptoms or worries. It also reminds providers of the possible benefits of the timely administration of SARS-CoV-2 monoclonal antibodies and other antivirals to prevent serious illness or hospitalization.

COVID-19 concerns are topline in medical settings these days and the demands for care can overwhelm some medical facilities. So triaging who gets attention and more intensive management becomes a necessity. CLL Society encourages you to fax, email, or otherwise draw your healthcare provider’s attention to this letter with a printed copy!

The CLL Society is invested in your long life. Please invest in the long life of the CLL Society.

Updated: 2/1/2022.

RECENT NEWS

When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.